cardiology

News in brief: Hypothermic ex-vivo perfusion trialled for donor hearts; Prehypertension accelerates brain ageing by six months; VTE prophylaxis death blamed on EMR failings;

Hypothermic ex-vivo perfusion trialled for donor hearts Cardiothoracic surgeons across Australia are embarking on a trial of ‘hypothermic ex-vivo perfusion’ to preserve donor hearts for a longer duration during transit. Co-principal investigator, Professor David McGiffin of The Alfred, Melbourne, said the Swedish-developed XVIVO Perfusion device pumps perfusate through the heart muscle, cooling it to 8°c ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic